ArticleBiologics : targets & therapy2018

Efficacy of ustekinumab against infliximab-induced psoriasis and arthritis associated with Crohn's disease.

Satohiro Matsumoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.